Shares of Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF - Get Free Report) shot up 33.6% during trading on Friday . The company traded as high as $65.44 and last traded at $65.44. 300 shares traded hands during mid-day trading, a decline of 65% from the average session volume of 850 shares. The stock had previously closed at $49.00.
Recordati Industria Chimica e Farmaceutica Stock Performance
The firm has a market cap of $13.50 billion, a PE ratio of 32.72 and a beta of 0.17. The stock's 50 day simple moving average is $54.50 and its 200 day simple moving average is $54.66.
Recordati Industria Chimica e Farmaceutica Company Profile
(
Get Free Report)
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
Further Reading
Before you consider Recordati Industria Chimica E Farmaceutica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Recordati Industria Chimica E Farmaceutica wasn't on the list.
While Recordati Industria Chimica E Farmaceutica currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
